Abridge | Latest News & Updates - Feb 28, 2025 Release
Abridge has partnered with Inova Health to improve clinician satisfaction and patient experience...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Abridge
🌎 abridge.comAbridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.
Abridge - Latest News and Updates
- Abridge has partnered with Inova Health to improve clinician satisfaction and patient experience.
- Athenahealth adds Abridge capabilities to its services.
- Inova Health has selected Abridge to improve clinician satisfaction and patient experience by streamlining workflows and reducing administrative burdens.
- Brittany Wadas has joined Abridge as Director Enterprise Development-Commercial in the United States, previously serving as Property & Casualty Consultant at USI Insurance Services.
- Dan MacKinnon has joined Abridge as the Director of Enterprise Development in Greater Boston, previously serving as a Healthcare Account Executive at Microsoft.
- Rachel Hope has joined Abridge as Clinical Success Director in the United States, previously serving as Physician Lead for EMR Optimization at AbsoluteCare.
- Abridge will have a booth at HIMSS25 in Las Vegas on March 3-6.
- Abridge is reportedly considering a move to Silicon Valley, raising concerns about Pittsburgh's economic stagnation.
- Abridge grew its annual recurring revenue from single-digit millions to nearly $100 million in just over a year by appealing to clinicians, patients, and operators of major health systems like UPMC.
- Abridge shared a Fortune profile on Shivdev Rao, highlighting his journey from cardiologist to entrepreneur and AI innovator, and featuring insights from Julia Chou, Zachary Lipton, and investors.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
